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Background: Opioid prescribing following bariatric surgery has been a focus due to its association with new
persistent opioid use (NPOU) and worse outcomes. Guidelines have led to a reduction in opioids prescribed, but
there remains variation in prescribing practices.
Methods: We conducted interviews with 20 bariatric surgeons across Michigan. Transcripts were analyzed using
descriptive content analysis.
Results: At the patient level, surgeons described the role of surgical history and pain tolerance. At the provider
level, surgeons discussed patient dissatisfaction, reputation, and workload. At the institution level, surgeons
discussed colleagues, resources, and administration. At a collaborative level, surgeons described the role of evi
dence and performance measures. There was lack of consensus on whether NPOU is a problem facing patients
undergoing bariatric surgery.
Conclusion: Despite efforts aimed at addressing opioid prescribing, variability exists in prescribing practices.
Understanding determinants that impact stakeholder alignment is critical to increasing adherence to guidelineconcordant care.

1. Introduction
New persistent opioid use (NPOU) is a common post-operative
complication for patients undergoing bariatric surgery with 4–9% of
opioid naive patients developing iatrogenic opioid dependence
following their index operation.1–8 For patients undergoing bariatric
surgery, NPOU is associated with significantly worse physiologic and
psychological outcomes, including decreased weight loss, decreased
patient satisfaction, and less improvement in psychological wellbeing.9
Despite increased awareness of the link between post-operative opioid
prescriptions and NPOU, opioids remain the cornerstone of pain man
agement following bariatric surgery.9–11
Currently, there are several evidence-based guidelines to inform
discharge opioid prescribing following bariatric surgery.12–14 In the
state of Michigan, there are targeted programs and initiatives aimed at
reducing opioid prescribing among providers through the use of
guidelines as well as a modifier 22 linked to opioid prescribing at

discharge.15 One example of these guidelines includes the imple
mentation of a pain control optimization pathway, which leverages
multi-modal analgesic management and patient education by Michigan
OPEN.16 The introduction of such guidelines has increased awareness of
excessive opioid prescribing and the effectiveness of opioid alternatives
for post-operative pain management, and has resulted in recommenda
tions that prescriptions for post-operative opioids be reduced after
bariatric surgery.15,17 Despite these successes, however, variation re
mains in the number of opioids prescribed by surgeons following bar
iatric surgery. Furthermore, there is evidence that these guidelines may
be set too high for some patients (e.g., opioid-naïve or those who do not
take anything after surgery) and too low for others (e.g., opioid-exposed
or other risk fathers).17,18 Although a growing body of research suggests
the need for stakeholder buy-in for adherence to guidelines,19–21 there is
currently a paucity of studies examining the beliefs that guide bariatric
surgeons’ opioid prescription practices.
In this context, we conducted a qualitative study of bariatric
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surgeons across Michigan to explore beliefs and practices in discharge
opioid prescriptions. Understanding the factors underlying this variation
may be another way to improve opioid prescription practices.

added to explore the topics raised. These data were not included in the
final analysis. This study was deemed exempt by the University of
Michigan’s Institutional Review Board.

2. Methods

2.1.1. Interview participants
Using convenience sampling, 20 surgeons were recruited via email
from bariatric programs across Michigan. Surgeons received participa
tion credit for the surgeon engagement measure on the pay-forperformance index.

2.1. Study design
Our team conducted a qualitative study to better understand
discharge opioid prescribing beliefs and practices among bariatric sur
geons across Michigan. NPOU was defined as a previously opioid-naïve
patient who self-reported opioid use one year after surgery. The guide
was piloted for content validity, presentation, and clarity of information
by two bariatric surgeons (Table 1). Additional questions and were

2.2. Interview procedures
Surgeons verbally consented to participate before the interview. In
dividual interviews were conducted by an anthropologist (CAV) with
experience in qualitative research. Interviews were conducted over the
phone or zoom from April to August 2021. None of the surgeons was
acquainted with the interviewer. The interviews lasted 30–45 min and
were digitally recorded, transcribed verbatim, and de-identified. Ob
servations from each interview were included in the analysis. We
continued to interview until data saturation was reached, defined as the
time when no new themes or major dimensions of themes were identi
fied.22 Transcripts were not returned to surgeons for review.

Table 1
Factors influencing discharge prescribing practices.
Tell me about the demographics of
bariatric surgery patients at your
hospital.

Can you walk me through the steps you
take in managing pain in bariatric
surgery patients?

Can you tell me about any patient level
factors that are considered when
making decisions about managing
pain?

Walk me through the process that
happens if a patient calls asking for a
refill.
Tell me about practice guidelines that
exist for managing post-surgical pain.

In your opinion, how big of an issue is
NPOU in the bariatric surgery
population? Outside of the bariatric
population?
Would it surprise you to know that over
6% become NPU? Would you sense it
is a bigger or a smaller problem?

Any advice to other providers on how to
manage pain in bariatric patients?
Is there anything we haven’t covered
that you think would be important for
us to know?

• Do you think that your patients are
pretty similar to the broader
population of patients undergoing
bariatric surgery?
• If not, what do you think makes your
patients different from the average
bariatric surgery patient (e.g., certain
patients have higher pain levels;
insurance status)?
• In what ways, if any are bariatric
patients different from other surgical
patients?
• In what ways, if any, has your pain
management strategy changed over the
last few years?
• What educational or administrative
resources, if any, do you use to manage
patient pain?
• What policies, if any, does your
practice have regarding refilling opioid
prescriptions?
• If uniform strategy, how did you come
to that?
• If patient specific factors, what are
those factors and how do you decide
how many pills to give (e.g., overall
health, previous opioid use, social/
emotional support) ?

2.2.1. Analysis
Descriptive content analysis was used to analyze transcripts, allow
ing for a comprehensive summary of an area of interest that can be
particularly useful in providing detailed accounts of a phenomenon of
interest.23,24 Two members of our research team (CAV and APE) read
three transcripts to identify an initial set of codes. Meetings were held to
determine which codes were similar enough to be grouped together, or
distinct enough to remain on their own. These conversations were
iterative until agreement was reached. This preliminary codebook was
used to code two additional transcripts. A revised draft of the codebook
was created until it was agreed that no new ideas were emerging, and
the coders reported no difficulties in applying the codebook to the ex
cerpts. Definitions were created and revised throughout the coding
process to promote consistency across coders. Two coders then inde
pendently coded the remaining transcripts. Our team included members
with a range of training and experience, credentials, and backgrounds.
Transcripts were coded using MAXQDA 2018.
3. Results
Twenty bariatric surgeons were included in this study (Table 2).
Surgeon participants were between the ages of 34–79 (median 47) and
had been in practice for <1–40 years (median 14.2). Most participants
(95%) were men and white/non-Latinx (85%). Surgeons were recruited
from 17 sites across Michigan, with the majority practicing in urban
areas (90%) and teaching institutions (100%). Adjusted morphine
milligram equivalent (MMEs) prescribed in 2020 ranged between − 1.1
and 123.4 (median 62.4). The adjusted NPOU ranged from 1 to 21%
(median 4.58%).
Surgeons identified factors that influenced their discharge opioid
prescription practices at the patient, provider, institution, and collaborative
levels. Notably, there was a lack of consensus on whether NPOU is
problematic in patients undergoing bariatric surgery. Themes with
illustrative quotes are displayed in Tables 3–6.

• Tell me about guidelines that exist for
how much surgeons should prescribe
for certain procedures.
• Tell me about any education or
guidelines you have you received in
managing pain.
• Do you think there is consistency in
how opioids are prescribed in your
institution? What about in the state of
MI?

• What do you think accounts for
differences in these rates (e.g., provider
level factors, patient level factors)?
• What do you know about the NPOU
rate at your institution, in particular?
• What factors do you feel contribute to
this problem?
• How do we address this problem?

3.1. Is NPOU a problem?
There was significant variation in response to the question of
whether NPOU was a problem for patients undergoing bariatric surgery.
In some instances, surgeons asserted that, “I don’t think it’s an issue.”
(116), while others acknowledged it as a problem but not for their pa
tients. Still others found it to be a significant issue facing patients un
dergoing bariatric surgery, both inside and outside of their patient
2
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Table 2
Participant characteristics.

Table 3
Is NPOU a problem?

Category
Identified Gender
Age

Identified Race

Years in Practice

a

Type of Practice

Community
b

Adjusted MME Average 2020

b

Adjusted NPOU % 2020

Female
Male
30–39
40–49
50–59
60–69
70–79
White
Black
Middle Eastern
Middle Eastern and North African
≤5
6–10
11–15
16–20
>20
Teaching
Private
Community
Urban
Rural
0–30
31–60
61–90
>90
<2%
2–5%
>5%

N

%

1
19
4
9
5
1
1
16
2
1
1
4
5
3
4
4
20
1
1
18
2
3
6
8
3
4
12
4

5%
95%
20%
45%
25%
5%
5%
80%
10%
5%
5%
20%
25%
15%
20%
20%
100%
5%
5%
90%
10%
15%
30%
40%
15%
20%
60%
20%

“The bariatric population we know probably has a higher risk than the general
population for new persistent opioid use, so we’ll keep doing our best to help
prevent that from becoming a problem, at least in my regional area here.” (103)
“I’m going to say that now it’s really not that big of an issue for us. Again, if patients
are getting opioids, it’s not from our practice or because they had surgery with us.
They are getting them from other sources so I do feel pretty good about that.” (106)
“I think I probably downplay it just because I personally don’t see it that much, but
even if I had patients that were using it afterward, it’s kind of hard to know since you
tend to lose a lot of follow-up after the first year or two anyway.” (110)
“I think new persistent opioid use is a really interesting phenomenon. I think we’ve
impacted it, but maybe it hasn’t been all of our impact. In other words, what causes
it? That’s the first question, right?” (111)
“Oh, well again I know the data. So, it’s definitely a problem. Now, and it ranks kind of
middle of the pack with other post-surgical conditions as far as new persistent use. I
think we’ve seen it come down a good bit since implementation of some of these
kind of reduced opiate prescribing practices. But yeah, that’s what is tough. I
couldn’t tell you in my own patients what proportion have new persistent use.”
(112)
“That’s a tough question. I think statistically it’s certainly not the majority but when it
happens, it is a huge problem, and it is a big strain on the medical system as a
whole.” (ID 113)
“I would like to think that it’s not, but I know I’m probably underestimating it because
we know there is going to be a certain percentage of patients who do have a new
addiction to narcotics after surgery.” (117)
“With my bariatric patients it’s not been a problem.” (119)
“It’s not. Yeah, for the patient who has never been on an opioid, almost all of these
patients get by with very few, frequently you’ll have patients who say I’ve never
even filled the script. So, I don’t think there’s any real persistent use. The people that
we have the problems with are the ones that were already on the medication who
want more, want stronger.” (120)
“I don’t believe it’s a problem, to be honest with you. Again, coming from a different
culture, I think also now we are doing exactly the opposite of what we were doing
before, and this is – again, we don’t have a happy medium. Now we are focusing –
you should never do this, people are giving zero narcotics, people are – come on,
guys! We can’t be just normal people?” (121)

a

Multiple practice sites.
These data were collected through the Michigan Bariatric Surgical Collab
orative, a statewide quality improvement collaborative focused on improving
outcomes for patients undergoing bariatric surgery. The collaborative creates
and reports risk and reliability adjusted values of MME’s prescribed. Statistical
risk adjustments are made at the patient level by taking into account patient
factors (i.e., age, sex, race/ethnicity, etc.) as well as comorbidities (i.e., hyper
lipidemia, high blood pressure, etc.). Reliability adjustment is also employed
which takes into account either surgeon or site (depending on which level we are
reporting at) and this will account for the patient mix at the surgical center/of
the surgeon and/or any actions (specified or unspecified, but mostly unspeci
fied) taken by the site or surgeon to reduce the amount of opioids they prescribe.
b

Table 4
Prescribing practices.
“And over the last several months we’ve made a push to go down to 8 pills of 5 mg of
oxycodone.” (104)
“In my practice it’s not uncommon at all for patients to never use a narcotic after
surgery, either in-patient or post-operatively and actually I still prescribe them or I
at least give them prescription for because it’s so difficult to manage that if they do
need it once they’re home and you don’t have a way to, you can’t like call in those
types of medications.” (105)
“If they do want any pain medication, usually, like the most we will send them home
are the eight of the 5 mg oxycodone at this point.” (110)
“Honestly, I don’t send anybody home with narcotics anymore.” (111)
“I give them seven pills of oxycodone and I tell them because some of them ask, well
that’s kind of a strange number, you know seven, and I say, well, we track this,
which we do, at our weight loss center. So, when I first started, I was giving about 15
pills of Norco actually before we really started tracking it and when I switched to
oxycodone, I was still giving them 10–15 pills and we found that most patients took
somewhere in the range of 0–4, so I’ve started giving 7 and I have yet to have had
somebody call me and ask me for more. I say it’s there, it’s available to you if you
absolutely need it but that’s sort of the typical scenario.” (113)
“They go home with Norco 5/325s, 10 tablets. I would say on average patients are
taking about half of those tablets. Gastric bypass patients tend to use them all
compared to sleeve patients.” (115)
“I don’t know if it’s, like I said, ten tablets. It probably could be a little bit less. But it’s
certainly not much more than the patients need. So, I think it also meets what
national society recommends right now. So, I think, I am comfortable there. Patients
are comfortable there. So, yeah, we’ll see, I might make some additional changes,
but probably not tremendously more. We’ll see.” (116)
“So sent a patient home with a prescription it’s going to be a total of 6 doses.” (117)
“We do, but I can’t quite quote what it is. I mean we – honestly, we want to be – we
want to prescribe less than three days’ worth of pain medication. Honestly, I don’t
know where that’s coming from, might be a hospital-wide thing.” (119)
“We probably will give up to ten. This is a new thing in the last few months, maybe last
year or so, 12 months or so. Other than this, we don’t really have actual protocol,
you know.” (121)

population. “It’s a huge problem. It certainly transfers dependencies,
transferring addictions … or even smoking, alcohol, and narcotic new use.”
(114).
3.2. Prescribing practices
When asked to describe their approach to discharge opioid pre
scriptions, some surgeons described how they were moving towards not
prescribing opioids for post-operative pain, “In the last six weeks, I
haven’t given out any narcotics.” (102). Others asserted sending patients
home with 6–15 pills. When surgeons who routinely prescribed opioids
were asked about efforts to decrease narcotics to zero, some described
the “strangeness” of not giving out any narcotics after surgery without
considering the context of the patient. Although most surgeons articu
lated an awareness of the guidelines that informed opioid prescribing
practices, it was most often in connection with performance measures
and not the evidence that connected prescribing practices to NPOU or
worse patient outcomes.
At some sites, discharge opioid prescription protocols were stan
dardized and out of the surgeon’s control, with every patient receiving
the same amount. At other sites, this process was individualized based
on patient factors, including the operation that the patient received,
“The sleeve seems to be a little bit more sore just because of the extraction site.
Those I may send with 10-12 tablets of Norco.” (114).
In some instances, surgeons asserted prescribing the same number of
opioids to every patient. Others preferred the use of other nonsteroidal
3
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Table 5
Managing refills.

Table 6
Factors influencing discharge prescribing practices.

“I said, “Because I don’t have a good reason for you to have to need extra pain
medicine, so you need to come in and let me take a look at you to make sure there’s
nothing going on,” and that’s usually enough to get them to not come in. They
usually don’t want to.” (102)
“We pretty much have a policy that, you know, within three weeks after surgery we
would not fill anybody’s prescriptions for opioids, unless they could show that they
had a surgical pain issue. So that patient would have to be seen, or you know, maybe
seen in the ER, have a CAT scan or they have, you know, evidence of a surgical
complication.” (106)
“Oh, I don’t refill them.” (109)
“I would say usually over the phone unless I had concerns that it was, you know,
severe pain or something that I needed to physically evaluate.” (110)
“Yeah, so the inquiries go not to our PAs, they actually go to our clinic nurses who then
contact us directly for refills. I can say with pretty good confidence, that I’ve not had
a post bariatric surgery patient approach me for refills. Pretty confident that I
haven’t had any.” 112)
“So, all of our patients will leave the hospital with a wrist band and a card with a
phone number on it. That phone number goes to the nursing station on the bariatric
floor and then the nurse will contact either the operating surgeon or the bariatric
surgeon on call and they provide us the patient’s name, surgery date, and a phone
number to contact that patient back. So, we get various calls for various reasons.
Some of those are pain and so that’s sort of the process about if they have pain
postoperatively, that’s how they contact us. Then sort of take it on a case-by-case
basis. Do they need a quicker follow-up appointment? Or kind of what else needs to
be done, but it’s a very individualized process.” (113)
“Yeah, so if it’s on the weekend it’s going to go either straight to myself or [redacted].
And so, you get a phone call from the answering service that this patient is in pain,
so basically the process would be you’d have a conversation with them to determine
whether or not it was something that really needs a narcotic, maybe they just need
ice packs, heat, maybe they need to be on five days of Neurontin, maybe they need
to come in and be seen on Monday. So, I would say probably one in ten of those
patients that call that you actually log in to the computer and send them over some
pain medication.” (115)
“Usually, our medical assistant would take that phone call from the patient. They
typically reach out to the surgeon that did the surgery. With the electronic medical
record, it’s gotten a lot easier to refill those prescriptions.” (117)
“And if it’s actual pain and I’m available I could have them come by to see me in the
office, you know. If it sounds like they really need something at that time, you know,
I’ll send it in.” (119)

Patient Level

Provider Level

anti-inflammatory drugs, muscle relaxers, non-opioid pain relievers, and
abdominal binders as effective ways to manage pain. Finally, in some
instances, surgeons asserted that what they prescribed was based on
insurance coverage. For example, one surgeon described their prefer
ence for prescribing Tylenol and Celebrex, but that coverage was diffi
cult to obtain.
3.3. Managing refills

Institutional
Level

Although most surgeons asserted that there were few refill requests
for patients undergoing bariatric surgery, the processes in place to
manage these requests varied. While some providers required an office
visit before fulfilling a request, others managed this process over the
phone. Additionally, some surgeons asserted that they would only offer
non-narcotic alternatives to patients. While others stated that they
would offer a refill prior to requiring an in-person visit from the patient.
3.4. Factors influencing beliefs and practices
In exploring the determinants of this variation in beliefs and prac
tices, surgeons described
Patient-, provider-, institution-, and collaborative-level factors.
Patient Level.
At the patient level, surgeons discussed how surgical history, patient
demographics, previous medication use, addiction history, and the
subjective nature of pain influenced discharge opioid prescription
practices.

“You can kind of tell with people, even if they have no history of
using any pain medication or narcotic pain medication in the past,
you can kind of get a sense of what patients you have that are going
to request additional narcotics or are going to have more issues of
pain control postoperatively, and it’s a little bit of a hard thing to
pinpoint. But I would certainly guess that mental health and
psychosocial support all kind of play a role in that.” (110)
“I mean I think it can come in psychiatric diagnoses, history of any
kind of substance abuse. I mean I think there’s some definite
predictors of new persistent use. But that being said, it should
influence in a positive direction what you do perioperatively, like
how much you’re giving. So why there still continues to be such wide
variation in what people are giving in the time of surgery is a little
befuddling.” (112)
“I think when you have guidelines, it works for the majority of the
patient; but always, there will be exceptions that you have to bend the
guidelines either way.” (114)
“But it’s likely going to be a gastric bypass patient more so than
sleeve patient requesting a refill. They have a few more incisions that
are bigger that require closure of the port site, so they tend to have a
little bit more discomfort.” (115)
“So obviously everyone’s experience of pain is not the same. That
goes back to the whole Joint Commission, pain being the fifth vital
sign. Pain is not an objective measurement; it’s a subjective
measurement so it’s really hard to quantify.” (117)
“Usually, younger patients sometimes they will be tough. And some
patients with chronic pain issue and then they will also be challenging
somehow.” (121)
“A lot of people get in a grind of you do the same thing because it
works. And sometimes when literature comes out, you kind of look at
it and go, “Yeah, but mine works anyways. It’s not big enough for me
to make a change.” (102)
“But I’d say 80% of the time there can be influences based on
prescribing habits of the actual person doing the prescribing. So, I
think that’s probably the majority of what creates that variation.”
(104)
“I mean I guess if it works for them then great, then maybe I should
be doing it too. Personally, I’m retiring in two months and to start a
new program – okay, I’m at the point where it doesn’t really matter.”
(107)
“I can’t imagine that anyone would – I can because surgeons are
obstinate, but like you know, why you would think your patients are
so different that you can’t just prescribe fewer opioids.” (112)
“Where I did my training, we were one of the pilot sites for the
ENERGY Program so I really carried over a lot of that into starting
my practice and so I always sort of try to limit the amount of narcotic
just little things like not doing a routine swallow study, not doing
routine drains, not doing routine foleys, sort of multimodal pain
management and discussing with them preoperatively, kind of
expectations, I think just really kind of helps.” (113)
“And I’ve almost found it like the path of least resistance to send
people with, like a paper script for, you know, five oxycodone or
something like that, that they can fill if they need to. Unfortunately,
like, even if they don’t fill it, then that counts as basically they’ve
been prescribed that medication. So, I am not opposed to going down
on it, or it’s just sort of a matter of like, what kind of phone contact
and outpatient contact that’s going to generate for us because a lot of
that I have to do myself.” (110)
“The sort of interesting thing from our own internal data is that the
more pills that are prescribed, the more pills they take. So that’s what
kind of gave me sort of the idea to just cut the amount down to seven
because the vast majority, like I said, were taking between zero and
four opioid pills and that’s five of oxycodone in my practice. But if
we looked at the earlier data, if we were prescribing them that 15
then they were taking 8 or 9, so whatever that’s worth.” (113)
“Yeah, so I think it probably has to do with the process of the
program of how they’re prescribing the medication. Are refills always
being granted, is there a process in place for how they’re dealing with
that? So, I think it’s probably more – some practices it may just be
easier for those refills just to go out because it’s easier to just refill the
medication and you don’t have to bother the surgeon. With our
practice we have a lot of support. Nurse practitioners to help manage
it, so I think that’s understood.” (115)
“It’s the system. Like the system is literally teaching the patient and
the system by itself is like, again, you give them too much from this
candy and they want it … It’s just wrong. It all starts with the system,
(continued on next page)
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3.5. Provider level

Table 6 (continued )

Collaborative
Level

and we spoiled our patients. Literally. Again, when you practice in
different countries you see it. If you get the patient used to not giving
them anything, or very small – like I used to give them 20 or 30, they
will look at me like why I am doing this. I’m a bad doctor, I don’t
care, you know. And then I’d say, no, I do care. But then I start
hearing this because, again, the hospitals will be up against me, the
patient will start rating me bad. The whole system was wrong. And
we’re stuck in it, unfortunately, until we have a disaster after disaster
after disaster and then people start saying, well, let’s give the nurses
and the physician more rules to resist the patient’s satisfaction. And
then we started seeing more aggressive physician. They would say,
no, I can’t do it. I’m sorry, you need a pain specialist to do it. I can’t
do it. My excuse is what, do you know? I’m not allowed to do it. I
can’t. It’s not that I should not, it’s I can’t. Again, the explanation is
wrong because if I say anything else the patient will go and rate me
bad and, again, we still need a lot of time to break that cycle. But it’s
happening.” (121)
“It was by shaming of the Michigan Bariatric. When you see your
name kind of on the highest, I wasn’t the highest, but I was certainly
probably on the top 30 percentile of narcotic prescribers, you are
like, Ew, geez, something I’m doing wrong or something I’m doing
unnecessarily. And that prompt me to just, I mean, immediately after
I saw those numbers, I cut by 50%. And then slowly, I have been
titrating down based on the patient’s need and how many they used.”
(114)
“We also participate with another collaborative, MSQC … similar
type of concept, and so a lot of the information as far as the
recommendations for narcotic prescribing were coming from that,
and so we just kind of extend that to our bariatric population as
well.” (117)
“Well, you come in and you give more than three days of pain
medication. That’s going to be a demerit and you’re not following the
rules or the guidelines of the society or the government or the
program, and so you’re in a quagmire. You know what do you do? I
mean you’ve got to treat this patient. They’re telling you they have
pain. I have to treat that, and at the same time I’m getting penalized
for overprescribing. It’s a problem, and I mean that has to be
addressed because it’s not real. You know MBSC – you go to the
conference and say, well, you know a combination of – you know my
patients, they get no pain medicine, I mean they don’t get any
opioids. They go home and we give them some other medication that
replace that and get zero pain management. I couldn’t practice like
that, so that’s another perspective. That’s a different type of patient,
and that’s what I mean by the distribution of patients. It has to do
with people that have been exposed to different socioeconomic status,
and they’re going to react differently, and that’s something that
happens so you can’t just generalize and say we all do this, and these
are the rules of engagement, and you have to follow them, and if you
don’t follow them, you’re going to get a demerit.” (118)
“Well, you know, I think probably up until this was all being
addressed at the MBSC, we were giving 20. That was a pretty
standard number of pain pills. And so, you know, watching and
listening to what other groups were doing, if we can get this number
down, I think it’s the better thing to do.” (120)

At the provider level, some surgeons described negative re
percussions if the pain was left unmanaged.
“I cannot just send him without medication … They will go home without
anything or will go with three pills, and then they will call my office, their
primary care office. The primary will be very angry because we do not
care … Patients will swear they will never come back to me.” (121)
Surgeons also discussed how factors such as experience, years in
practice, and training influenced their approach to discharge opioid
prescribing – with those earlier in their career bringing forward ideas
that were addressed in their training, while those later in their career
asserted being close to retirement as a reason not to change practice.
Others discussed how their involvement with influenced their approach
to pain management.
3.5.1. Institutional level
At the institutional level, other bariatric surgeons influenced practice
patterns, with some describing consistency among providers as facili
tators for adopting practices. Surgeons also described variations in the
resources available at their institutions. At some institutions, the task of
prescribing pain medication was delegated to someone else on the care
team, alleviating the potential burden when making decisions about
managing pain. At other institutions, the surgeon was the main point of
contact for patients and had some hesitation in reducing the narcotics
prescribed due to the potential for increased workload.
“We have limited staff, and so if we cut it down too much, are we going to
be bombarded with calls … You are weighing all the things. you are
weighing the burden on your staff, dissatisfaction with patients, all that
has to come into play.” (115)
Additionally, surgeons articulated receiving pressure from their
institution to reduce MMEs. For some, this was considered positive and
helped to ensure that they were not outliers. For others, this practice was
viewed as not delivering patient-centered care. Finally, surgeons in
lower volume programs sometimes expressed frustration that for sur
geons not at high-volume sites, even a few extra medications resulted in
them being over on MMEs, potentially impacting their ability to obtain
pay-for-performance.
3.6. Quality improvement collaborative
Most surgeons described groups like the Michigan Bariatric Surgical
Collaborative as being at the forefront of conversations on discharge
opioid prescriptions and provided evidence that guided their practice
patterns. Many asserted that knowing where they stood against their
peers encouraged them to not be outliers. “You get to see your data up
against everybody else’s and it’s eye-opening.” (113).
However, for some, these metrics were not seen as reflective of the
variation in their patient populations and articulated a need for more
support at sites where patient demographics were not reflective of the
average, such as those with a high percentage of patients who utilized
Medicaid and Medicare.

“You’ll have a lady who has given birth four times, probably doesn’t need
anything. A young man may require a lot of pain medication. Everybody’s
perception is different.” (120)
Surgeons also described variations in how they managed patients
with previous histories of opioid use. Some surgeons asserted consulting
specialists early, obtaining approval before surgery, and adhering to any
pain plan in place. Some surgeons reported prescribing the same number
of pills that they would for any other patient, but sent the patient back to
the specialist for any additional requests. Others stated that rather than
prescribing opioids, they would send the patient back to the specialist
who originally prescribed the opioid. Finally, some surgeons followed
up with patients to identify patient-reported opioid use, which influ
enced how many opioids future patients were sent home by providing
them with an accurate assessment of how many pill patients were
taking.

“I’m punished because I’m overprescribing on patients that have a whole
different perspective in terms of their pain needs … If you are giving
opioids, then you are not meeting the standard of care, and I mean you
cannot judge it like that.” (118)
4. Discussion
Surgeons identified factors that influence their discharge opioid
prescription practices at the patient, provider, institution, and collabo
rative levels. Notably, there was a lack of consensus on whether NPOU is
problematic in patients undergoing bariatric surgery. Understanding the
5
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determinants that impact stakeholder alignment and proficiency on this
topic is critical to the development of tailored interventions aimed at
increasing adherence to guideline-concordant care.
A robust body of literature points to the fact that standardization
increases adherence to evidence-based practices, which are associated
with better treatment outcomes. Despite the known benefits of adhering
to these practices, variations remain in providers’ adherence to
evidence-based guidelines. Interventions that attempt to address this
variation often assume that a lack of awareness of guidelines is the main
reason for non-adherence.25 However, as our data highlight and previ
ous research suggests, this assumption is often reductionist and fails to
consider the multitude of other factors that impact not only practice but
behavior change.26 As our data highlight, the reasons for non-adherence
are often complex. For example, in some cases, guideline nonadherence
may be intentional if surgeons perceive that the recommended opioid
prescription will not sufficiently treat the patient’s pain. Building on
previous research, surgeons from this study asserted a belief that their
patients are different; therefore, adhering to strict guidelines or reducing
opioid prescribing any further would be detrimental to patient care.26,27
To further improve practices around discharge opioid prescribing, we
need to understand the reasons for non-adherence by exploring contexts
and understanding that strategies that work in one setting may be less
useful in other settings where factors influencing behavior are
different.25
In our study, we found that despite being aware of the guidelines,
surgeons’ beliefs about whether NPOU was a problem for patients un
dergoing bariatric surgery were quite varied. As previous research
suggests, surgeons’ recognition of a problem may have a direct influence
on their adherence to guidelines.25,28 Further, even with guidelines in
place, opioid prescribing is not often patient-centered, leading to over
prescribing for most patients and under prescribing for others.6,29 This
could be, at least in part, due to the complexity of patient risk factors
that also underlie NPOU. Therefore, surgeons may be more or less likely
to follow the guidelines for opioid stewardship for the community based
on their own beliefs about how their actions contribute to the problem.
One potential means to address this is to create a mechanism that tracks
patient-reported opioid use and then use it as a baseline for each indi
vidual hospital or clinic. This would complement many of the guidelines
in this space, including the Michigan Pain-control Optimization
Pathway and Michigan Open Guidelines.16,30 This would not only help
in the creation of additional evidence on potential differences based on
patient factors, but could also serve as a way of flagging patients that
may need more attention or follow-up. As previous research suggests,
even where evidence exists, surgeons tend to rely on anecdotes more
than evidence.31 Greater insight into context-specific situations will
allow for greater anecdotal evidence that decisions are often based on.
This will allow surgeons to not only adjust their own discharge opioid
prescribing practices, but also smooth transitions of care across pro
viders for patients with ongoing pain management needs outside of the
3-month post-operative period, which is typically considered the win
dow of acute post-operative pain.32
To facilitate this process, we must also address a second major factor
in adherence to guidelines: the variation that exists in institutional re
sources and the need to further support surgeons from less resourced
institutions. In our study, surgeons pointed out how variation in re
sources impacted their approach to discharge opioid prescriptions. For
example, bariatric surgeons from higher-resourced institutions often
acknowledge having other team members in place that oversaw
screening calls from patients regarding post-operative concerns or refill
requests. In contrast, surgeons at less resourced institutions discussed
being the main contact for patients and their pain. In these instances,
surgeons described their discharge prescribing practices as a way of
mitigating inconvenience for patients (who were often described as
having greater needs), as well as additional workload for themselves.
This problem is not specific to bariatric surgery and is likely experienced
in other elective and/or preference-sensitive conditions. For example,

the practice of “convenience prescribing” opioids to patients in advance
of elective inguinal hernia repair is associated with a significantly
increased risk of NPOU after surgery.33 While beneficial, a potential
limitation of large-scale quality improvement projects is that they are
often making population-level recommendations, ignoring the fact that
individual surgeons and institutions have different access to resources. If
we are committed to population health, we must ensure that we are
drafting and implementing guidelines with provisions for less-resourced
hospitals. In other words, we must view the establishment of these
guidelines through an equity lens. As previous research has highlighted,
we should rely on systems rather than individual clinicians.25 But what
are the implications of these initiatives when the resources available at
hospitals vary? For guidelines to be equitably adopted, we need to
address the factors that impact the ability of surgeons to adhere.
We acknowledge that our study has some limitations that should be
considered. We employed convenience sampling instead of purposeful
sampling to avoid an undue burden on the population with limited
availability. Future studies should incorporate a purposeful approach
that allows us to connect outcomes. The data generated from this study
is specific to bariatric surgeons in Michigan and is not likely to be
representative of views from bariatric surgeons across the country. We
acknowledge that our study population was rather homogenous. How
ever, it is worth noting that this sample is reflective of surgeons and
practices that are part of MBSC (86% male, 90% teaching, 90% urban,
73% white). Additionally, variation is complicated, and surgeon
behavior represents only one dimension of the mechanisms that underlie
variation. Future studies should focus on the perspectives of other pro
viders who are filling out prescriptions and talking to patients at
discharge (e.g., clinic staff, residents/fellows, NP/PAs/RNs). Finally, the
patient level factors presented are based on perspectives of the surgeons.
Future studies should focus on the voice of patients.
5. Conclusion
Despite efforts aimed at addressing opioid prescriptions, variability
exists in prescribing practices and beliefs among bariatric surgeons
across Michigan. To address this variation and develop further guide
lines aimed at opioid discharge practices, we must closely consider the
contexts and factors that may impact stakeholder alignment and
proficiency.
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